OB-002H Gel Administered Vaginally and Rectally in HIV-1 Seronegative Adults

NCT04791007 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Prevention

Interventions

DRUG: OB-002
DRUG: Placebo

Sponsor

Orion Biotechnology Polska Sp. z o.o.

Collaborators

[object Object]